Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 3138-3145

  Kuklin, Nelly ^a   Daheshia, Massoud ^a   Karem, Kevin ^a   Manickan, Elanchezhiyan ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; MEDROXYPROGESTERONE ACETATE; PLASMID DNA; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030932988     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.3138-3145.1997     Document Type: Article

References (32)

1. Donnelly, J. J., J. B. Ulmer, and M. A. Liu. 1994. Immunization with polynucleotides. A novel approach to vaccination. Immunologist 211:20-25.
2. Eis-Hubinger, A. M., D. S. Schmidt, and K. E. Schneweis. 1993. Antiglycoprotein B monoclonal antibody protects T cell depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol. 74:379-385.
3. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
4. Gallichan, W. S., and K. L. Rosenthal. 1995. Specific secretory immune responses in female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13:1588-1595.
5. Gallichan, W. S., and K. L. Rosenthal. Effects of estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex-2 infection in the genital tract. Virology, in press.
6. Gallichan, W. S., D. C. Johnson, F. L. Graham, and K. L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168:622-629.
7. Gould-Fogerite, S., and R. J. Mannino. 1996. Mucosal and systemic immunization using cochleate and liposome vaccines. J. Liposome Res. 6:357-379.
8. Holmgren, J., N. Lycke, and C. Czerkinsky. 1993. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 12:1179-1185.
9. Kanangat, S., A. Solomon, and B. T. Rouse. 1992. Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules. Mol. Immunol. 29:1229-1234.
10. + T cells. J. Virol. 69:4711-4716.
11. Manickan, E., R. J. D. Rouse, Z. Yu, W. Wire, and B. T. Rouse. 1995. Genetic immunization against herpes simplex virus. Protection is mediated by CD4 T lymphocytes. J. Immunol. 155:259-265.
12. Marinario, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J. R. McGhee. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL4. J. Immunol. 155:4621-4623.
13. McDermott, M. R., L. J. Brais, and M. J. Evelegh. 1990. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 71:1497-1504.
14. McDermott, M. R., G. H. Goldsmith, K. L. Rosenthal, and L. S. Brais. 1989. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159:460-466.
15. McDermott, M. R., J. R. Smiley, P. Leslie, J. Brais, H. E. Rudzroga, and J. Bienenstock. 1984. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:747-753.
16. Milligan, G. N., and D. I. Bernstein. 1995. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 206:234-241.
17. Nair, S., A. M. J. Buiting, R. J. D. Rouse, N. V. van Rooijen, L. Huang, and B. T. Rouse. 1995. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int. Immunol. 7:679-688.
18. Pardoll, D. M., and A. M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165-169.
19. Parr, M. B., L. Kepple, M. R. McDermott, M. D. Drew, J. J. Bozzola, and E. L. Parr. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex type 2. Lab. Invest. 70:369-380.
20. Raz, E., A. Watanabe, S. M. Baird, R. A. Eisenberg, T. B. Parr, M. Lotz, T. J. Kipps, and D. A. Carson. 1993. Systemic immunological effects of cytokine genes injected into the skeletal muscle. Proc. Natl. Acad. Sci. USA 90:4523-4527.
21. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
22. Spear, P. G., and B. Roizman. 1972. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J. Virol. 9:143-159.
23. Staats, H. F., R. J. Jackson, M. Marinaro, I. Takahashi, H. Kiyono, and J. R. McGhee. 1994. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immunol. 6:572-583.
24. Staats, H. F., W. G. Nichols, and T. J. Palker. 1993. Mucosal immunity to HIV: systemic and vaginal antibody responses after intranasal immunization with HIV C4/V3 peptide TISPIOMN (A)′. J. Immunol. 157:462-472.
25. Staats, H. F. Personal communication.
26. Stanberry, L. R. 1996. Herpes immunization - on the threshold. J. Eur. Acad. Dermatol. Veneriol. 7:120-128.
27. Stribling, R., E. Brunette, D. Liggitt, K. Gaensler, and R. Debs. 1992. Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. USA 89:11277-11281.
28. Ulmer, J. B., J. C. Sadoff, and M. A. Liu. 1996. DNA vaccines. Curr. Opin. Immunol. 8:531-536.
29. Whaley, K. J., L. Zeitlin, R. A. Barratt, T. E. Hoen, and R. A. Cone. 1994. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J. Infect. Dis. 169:647-649.
30. Wheeler, C. J., P. L. Feligner, Y. J. Tsai, J. Marshall, L. Sukhu, S. G. Don, J. Hartikka, J. Nietupski, M. Manthorpe, M. Nichols, M. Plewe, H. Liang, J. Norman, A. Smith, and S. H. Cheng. 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA 93:11454-11459.
31. Wu, H. Y., and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with cholera toxin B subunit. Infect. Immun. 61:314-322.
32. Xiang, Z., and H. C. J. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135.